Skip to main content
Top
Published in: Journal of Neurology 8/2021

01-08-2021 | Spinocerebellar Ataxia | Review

Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis

Authors: Alhassane Diallo, Heike Jacobi, Sophie Tezenas du Montcel, Thomas Klockgether

Published in: Journal of Neurology | Issue 8/2021

Login to get access

Abstract

Background

Spinocerebellar ataxias (SCAs) are rare dominantly inherited neurodegenerative disorders that lead to severe disability and premature death.

Objective

To better characterize the natural history of the most common SCAs, SCA1, SCA2, SCA3 and SCA6, we performed a meta-analysis of literature to determine disease progression, provide data for sample-sizes calculations for interventional trials and study the impact of geographical locations and study follow-up on disease progression.

Methods

A systematic literature search from MEDLINE and EMBASE databases for longitudinal natural history studies of SCA patients was conducted. Studies using the Scale for the Assessment and Rating Ataxia (SARA) as outcome measure were considered. Random-effect (RE) meta-analysis was applied to estimate pooled disease progression.

Results

Six studies with 1215 SCA patients enrolled between 2005 and 2016 were finally selected. Annual pooled SARA score increase was 1.83 (1.46–2.20) in patients with SCA1, 1.40 (1.19–1.61) in patients with SCA2, 1.41 (0.97–1.84) in patients with SCA3, and 0.81 (0.66–0.97) in patients with SCA6. For patients with SCA3, disease progression was faster in studies located in Asia and Europe than in the US. Two-arm interventional trials of 1-year duration to achieve 80% power and α level of 5% would require 92 patients per group with SCA1, 97 with SCA2, 115 with SCA3, and 430 with SCA6 to detect a 50% reduction in disease progression.

Conclusion

This meta-analysis provides quantitative data on the progression of the most common spinocerebellar ataxias based on patient numbers that exceed those of previous studies and confirms that disease progression is faster in SCA1, intermediate in SCA2 and SCA3 and slower in SCA6, with similar rates of disease progression in SCA2 and SCA3 between different populations, suggesting a possibility of international collaborative studies. Nevertheless, individual-patient data meta-analysis is needed to better understand the risk factors that influence disease progression and improve patient stratification in interventional trials.
Appendix
Available only for authorised users
Literature
1.
go back to reference Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primer 5(1):24CrossRef Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primer 5(1):24CrossRef
2.
go back to reference Klockgether T, Lüdtke R, Kramer B, Abele M, Bürk K, Schöls L et al (1998) The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain J Neurol 121(4):589–600CrossRef Klockgether T, Lüdtke R, Kramer B, Abele M, Bürk K, Schöls L et al (1998) The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain J Neurol 121(4):589–600CrossRef
3.
go back to reference Lee Y, Liao Y, Wang P, Lee I-H, Lin K, Soong B (2011) Comparison of cerebellar ataxias: a three-year prospective longitudinal assessment. Mov Disord 26(11):2081–2087CrossRef Lee Y, Liao Y, Wang P, Lee I-H, Lin K, Soong B (2011) Comparison of cerebellar ataxias: a three-year prospective longitudinal assessment. Mov Disord 26(11):2081–2087CrossRef
4.
go back to reference Tezenas du Montcel S, Charles P, Goizet C, Marelli C, Ribaï P, Vincitorio CM, Anheim M, Guyant-Maréchal L, Le Bayon A, Vandenberghe N, Tchikviladzé M, Devos D, Le Ber I, N'Guyen K, Cazeneuve C, Tallaksen C, Stevanin G, Brice A, Durr A (2012) Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Arch Neurol 69:500CrossRef Tezenas du Montcel S, Charles P, Goizet C, Marelli C, Ribaï P, Vincitorio CM, Anheim M, Guyant-Maréchal L, Le Bayon A, Vandenberghe N, Tchikviladzé M, Devos D, Le Ber I, N'Guyen K, Cazeneuve C, Tallaksen C, Stevanin G, Brice A, Durr A (2012) Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Arch Neurol 69:500CrossRef
5.
go back to reference Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD et al (2013) Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis 8:177CrossRef Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD et al (2013) Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis 8:177CrossRef
6.
go back to reference Yasui K, Yabe I, Yoshida K, Kanai K, Arai K, Ito M et al (2014) A 3-year cohort study of the natural history of spinocerebellar ataxia type 6 in Japan. Orphanet J Rare Dis 9(1):118CrossRef Yasui K, Yabe I, Yoshida K, Kanai K, Arai K, Ito M et al (2014) A 3-year cohort study of the natural history of spinocerebellar ataxia type 6 in Japan. Orphanet J Rare Dis 9(1):118CrossRef
7.
go back to reference Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R et al (2015) Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol 14(11):1101–1108CrossRef Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R et al (2015) Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol 14(11):1101–1108CrossRef
8.
go back to reference On behalf of Rede Neurogenética, Monte TL, da Reckziegel ER, Augustin MC, Locks-Coelho LD, Santos ASP et al (2018) The progression rate of spinocerebellar ataxia type 2 changes with stage of disease. Orphanet J Rare Dis Internet 13(1):20CrossRef On behalf of Rede Neurogenética, Monte TL, da Reckziegel ER, Augustin MC, Locks-Coelho LD, Santos ASP et al (2018) The progression rate of spinocerebellar ataxia type 2 changes with stage of disease. Orphanet J Rare Dis Internet 13(1):20CrossRef
9.
go back to reference Lin Y-C, Lee Y-C, Hsu T-Y, Liao Y-C, Soong B-W (2019) Comparable progression of spinocerebellar ataxias between Caucasians and Chinese. Parkinsonism Relat Disord 62:156–162CrossRef Lin Y-C, Lee Y-C, Hsu T-Y, Liao Y-C, Soong B-W (2019) Comparable progression of spinocerebellar ataxias between Caucasians and Chinese. Parkinsonism Relat Disord 62:156–162CrossRef
10.
go back to reference Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66(11):1717–1720CrossRef Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66(11):1717–1720CrossRef
11.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRef
12.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef
13.
go back to reference Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRef Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRef
14.
go back to reference Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRef Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRef
15.
go back to reference Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRef Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRef
16.
go back to reference Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K et al (1997) International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 145(2):205–211CrossRef Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K et al (1997) International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 145(2):205–211CrossRef
17.
go back to reference Jardim LB, Hauser L, Kieling C, Saute JAM, Xavier R, Rieder CRM et al (2010) Progression rate of neurological deficits in a 10-year cohort of SCA3 patients. Cerebellum 9(3):419–428CrossRef Jardim LB, Hauser L, Kieling C, Saute JAM, Xavier R, Rieder CRM et al (2010) Progression rate of neurological deficits in a 10-year cohort of SCA3 patients. Cerebellum 9(3):419–428CrossRef
18.
go back to reference França MC, D’Abreu A, Nucci A, Cendes F, Lopes-Cendes I (2009) Progression of ataxia in patients with Machado–Joseph disease. Mov Disord 24(9):1387–1390CrossRef França MC, D’Abreu A, Nucci A, Cendes F, Lopes-Cendes I (2009) Progression of ataxia in patients with Machado–Joseph disease. Mov Disord 24(9):1387–1390CrossRef
Metadata
Title
Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis
Authors
Alhassane Diallo
Heike Jacobi
Sophie Tezenas du Montcel
Thomas Klockgether
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 8/2021
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-09815-2

Other articles of this Issue 8/2021

Journal of Neurology 8/2021 Go to the issue